MassSQUIRM: An assay for quantitative measurement of lysine demethylase activity

Epigenetics

Volumn 6, Issue 4, 2011, Pages 491-500

  Blair, Lauren P ^a,c   Avaritt, Nathan L ^a   Huang, Rong ^b   Cole, Phillip A ^b   Taverna, Sean D ^b   Tackett, Alan J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LSD1; Lysine demethylase; Mass spectrometry; Monoamine oxidase (MAO) inhibitors; Reductive methylation

Indexed keywords

DNA; LYSINE DEMETHYLASE; TRANSFERASE; UNCLASSIFIED DRUG; AOF2 PROTEIN, HUMAN; HISTONE; HISTONE DEMETHYLASE;

ARTICLE; DNA DAMAGE; ENZYMATIC ASSAY; ENZYME ACTIVITY; GENE EXPRESSION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IN VIVO STUDY; MASS SPECTROMETRIC QUANTITATION USING ISOTOPIC REDUCTIVE METHYLATION; QUANTITATIVE ASSAY; AMINO ACID SEQUENCE; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS;

EUKARYOTA;

AMINO ACID SEQUENCE; HISTONE DEMETHYLASES; HISTONES; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA;

EID: 79953690322     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.4.14531     Document Type: Article

References (50)

1. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell 2007; 128:635-8.
2. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705.
3. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119:941-53.
4. Forneris F, Binda C, Vanoni MA, Battaglioli E, Mattevi A. Human histone demethylase LSD1 reads the histone code. J Biol Chem 2005; 280:41360-5.
5. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437:436-9.
6. Nicholson TB, Chen T. LSD1 demethylates histone and non-histone proteins. Epigenetics 2009; 4:129-32.
7. Mosammaparast N, Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 79:155-79.
8. Amente S, Bertoni A, Morano A, Lania L, Avvedimento EV, Majello B. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 29:3691-702.
9. Lakowski B, Roelens I, Jacob S. CoREST-like complexes regulate chromatin modification and neuronal gene expression. J Mol Neurosci 2006; 29:227-39.
10. Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005; 19:857-64.
11. Lim S, Metzger E, Schule R, Kirfel J, Buettner R. Epigenetic regulation of cancer growth by histone demethylases. Int J Cancer 2010; 127:1991-8.
12. Culhane JC, Cole PA. LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol 2007; 11:561-8.
13. Cole PA. Chemical probes for histone-modifying enzymes. Nat Chem Biol 2008; 4:590-7.
14. Chromatin protocols. Chellappan SP, ed. New York, NY: Humana Press 2009.
15. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 2007; 25:801-12.
16. Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, et al. Antibody validation. Biotechniques 48:197-209.
17. Connor C, Cheung I, Simon A, Jakovcevski M, Weng Z, Akbarian S. A simple method for improving the specificity of anti-methyl histone antibodies. Epigenetics 2010; 5:392-5.
18. Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, et al. The putative oncogene GASC1 demethylates tri-and dimethylated lysine 9 on histone H3. Nature 2006; 442:307-11.
19. Smith CM, Gafken PR, Zhang Z, Gottschling DE, Smith JB, Smith DL. Mass spectrometric quantification of acetylation at specific lysines within the amino-terminal tail of histone H4. Anal Biochem 2003; 316:23-33.
20. Tackett AJ, Dilworth DJ, Davey MJ, O'Donnell M, Aitchison JD, Rout MP, et al. Proteomic and genomic characterization of chromatin complexes at a boundary. J Cell Biol 2005; 169:35-47.
21. Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, et al. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 1993; 261:50-8.
22. Agger K, Christensen J, Cloos PA, Helin K. The emerging functions of histone demethylases. Curr Opin Genet Dev 2008; 18:159-68.
23. Schulze WX, Usadel B. Quantitation in mass-spectrometry-based proteomics. Annu Rev Plant Biol 61:491-516.
24. Lim S, Janzer A, Becker A, Zimmer A, Schule R, Buettner R, et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31:512-20.
25. Culhane JC, Wang D, Yen PM, Cole PA. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc 132:3164-76.
26. Yang M, Culhane JC, Szewczuk LM, Jalili P, Ball HL, Machius M, et al. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 2007; 46:8058-65.
27. Yang M, Culhane JC, Szewczuk LM, Gocke CB, Brautigam CA, Tomchick DR, et al. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation. Nat Struct Mol Biol 2007; 14:535-9.
28. Szewczuk LM, Culhane JC, Yang M, Majumdar A, Yu H, Cole PA. Mechanistic analysis of a suicide inactivator of histone demethylase LSD1. Biochemistry 2007; 46:6892-902.
29. Culhane JC, Szewczuk LM, Liu X, Da G, Marmorstein R, Cole PA. A mechanism-based inactivator for histone demethylase LSD1. J Am Chem Soc 2006; 128:4536-7.
30. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 2006; 66:11341-7.
31. Schulte JH, Lim S, Schramm A, Friedrichs N, Koster J, Versteeg R, et al. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 2009; 69:2065-71.
32. Huang Y, Stewart TM, Wu Y, Baylin SB, Marton LJ, Perkins B, et al. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res 2009; 15:7217-28.
33. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009; 138:660-72.
34. Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007; 446:882-7.
35. Lee MG, Norman J, Shilatifard A, Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 2007; 128:877-87.
36. Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437:432-5.
37. Beumer JH, Tawbi H. Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment. Curr Clin Pharmacol 2010; 5:196-208.
38. Mavers M, Ruderman EM, Perlman H. Intracellular signal pathways: potential for therapies. Curr Rheumatol Rep 2009; 11:378-85.
39. Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J, et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006; 125:483-95.
40. Fortschegger K, de Graaf P, Outchkourov NS, van Schaik FM, Timmers HT, Shiekhattar R. PHF8 targets histone methylation and RNA polymerase II to activate transcription. Mol Cell Biol 30:3286-98.
41. Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, Liu WT, et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 2010; 466:508-12.
42. Loenarz C, Ge W, Coleman ML, Rose NR, Cooper CD, Klose RJ, et al. PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nepsilon-dimethyl lysine demethylase. Hum Mol Genet 19:217-22.
43. Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, Gordon DB, et al. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466:503-7.
44. Suganuma T, Workman JL. Features of the PHF8/KIAA1718 histone demethylase. Cell Res 2010; 20:861-2.
45. Yu L, Wang Y, Huang S, Wang J, Deng Z, Zhang Q, et al. Structural insights into a novel histone demethylase PHF8. Cell Res 20:166-73.
46. Yue WW, Hozjan V, Ge W, Loenarz C, Cooper CD, Schofield CJ, et al. Crystal structure of the PHF8 Jumonji domain, an Nepsilon-methyl lysine demethylase. FEBS Lett 584:825-30.
47. Zhu Z, Wang Y, Li X, Xu L, Wang X, Sun T, et al. PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res 20:794-801.
48. Collom SL, Jamakhandi AP, Tackett AJ, Radominska-Pandya A, Miller GP. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling. Arch Biochem Biophys 2007; 459:59-69.
49. Gradolatto A, Rogers RS, Lavender H, Taverna SD, Allis CD, Aitchison JD, et al. Saccharomyces cerevisiae Yta7 Regulates Histone Gene Expression. Genetics 2008; 179:291-304.
50. Kurumizaka H, Wolffe AP. Sin mutations of histone H3: influence on nucleosome core structure and function. Mol Cell Biol 1997; 17:6953-69.